SOURCE: Gilead Sciences
DESCRIPTION:
The data we presented at ECCMID 2022 is part of Gilead’s mission to advance access to effective therapies. We've helped transform the treatment and prevention of HIV and delivered HCV cures as a result of our deep scientific understanding of viruses and expertise in antiviral drug development.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
KEYWORDS: NYSE:GILD, Gilead Sciences, ECCMID 2022
